PharmiWeb.com - Global Pharma News & Resources
31-Jan-2019

Uveal Melanoma - Pipeline Insight, 2019 by Developmental Stage, Associated Indications, Route of Administration, and Molecule Type - ResearchAndMarkets.com

The "Uveal Melanoma - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Uveal Melanoma - Pipeline Insight, 2019 offers a comprehensive insight of the pipeline (under development) therapeutics scenario and growth prospects across Uveal Melanoma development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Scope

  • The report provides a snapshot of the pipeline development for the Uveal Melanoma
  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Uveal Melanoma
  • The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Uveal Melanoma
  • The report also covers the dormant and discontinued pipeline projects related to Uveal Melanoma

Companies Featured

  • Bellicum Pharmaceuticals Inc.
  • Bristol-Myers Squibb Company
  • Celldex Therapeutics Inc.
  • Cleveland BioLabs Inc.
  • Delcath Systems Inc.
  • Eli Lilly and Company
  • Iconic Therapeutics Inc.
  • Immunocore Ltd.
  • Lion Biotechnologies Inc.

Topics Covered

1. Report Introduction

2. Uveal Melanoma Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Uveal Melanoma

4. Comparative Analysis

5. Products in Clinical Stage

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

  • Product Description
  • Research and Development
  • Product Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/n67gjp/uveal_melanoma?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190131005778/en/

Editor Details

Last Updated: 31-Jan-2019